Oliver James, MD
Pain Medicine · Lexington, KYNPI 1194727701
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.2% of the total across 179 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 17.3% — the pattern of someone who eats at a lot of different presentations.
Across 179 payments — averaging $26.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nevro Corp.$819
- Globus Medical$488
- Abbott$384
- Supernus Pharmaceuticals, Inc.$354
- Amgen$263
- Protega Pharmaceutials Inc$252
- plus $2K from 27 others
What the payments were for
- Food & beverage$4,68899%
- Education$361%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nevro Corp. | 15 | $819 |
| Globus Medical | 7 | $488 |
| Abbott | 10 | $384 |
| Supernus Pharmaceuticals, Inc. | 24 | $354 |
| Amgen | 13 | $263 |
| Protega Pharmaceutials Inc | 5 | $252 |
| AbbVie | 12 | $248 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 14 | $238 |
| Flowonix Medical Incorporated | 1 | $209 |
| Collegium Pharmaceutical, Inc. | 10 | $182 |
| MDD US Operations, LLC | 8 | $168 |
| Saluda Medical Americas, Inc. | 5 | $164 |
| Boston Scientific | 7 | $147 |
| Novartis | 4 | $88 |
| Pfizer | 5 | $81 |
| Scilex Pharmaceuticals Inc. | 4 | $65 |
| Teva Pharmaceuticals USA, Inc. | 4 | $58 |
| Kowa Pharmaceuticals America, Inc. | 3 | $53 |
| Medtronic(2 entities) | 3 | $51 |
| Indivior Inc. | 3 | $49 |
| Amneal Pharmaceuticals LLC | 3 | $48 |
| Almatica Pharma LLC | 2 | $38 |
| Valinor Pharma, LLC | 2 | $37 |
| Redhill Biopharma Inc. | 3 | $36 |
| Tersera Therapeutics LLC | 2 | $34 |
| Azurity Pharmaceuticals, Inc. | 2 | $34 |
| Arbor Pharmaceuticals, Inc. | 2 | $32 |
| Lundbeck LLC | 1 | $23 |
| Orexo US, Inc. | 1 | $21 |
| Pacira Therapeutics, Inc. | 1 | $17 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
| Daiichi Sankyo Inc. | 1 | $14 |
| Johnson & Johnson | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Omnia$416
- Senza$243
- Prometra II$209
- CORRIDOR$185
- Proclaim Family of SCS IPGs$129
How this compares
$4,724 in reported general payments places this provider in the 55th percentile of 90 pain medicine providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RelistorMethylnaltrexone Bromide | 306 | $712,615 |
| Xtampza ErOxycodone Myristate | 522 | $318,984 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 9,583 | $197,271 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 6,753 | $175,306 |
| MovantikNaloxegol Oxalate | 277 | $118,184 |
| BelbucaBuprenorphine Hcl | 179 | $116,238 |
| OxycontinOxycodone Hcl | 174 | $99,893 |
| Oxycodone Hcl | 2,743 | $79,337 |
| Gabapentin | 8,205 | $78,477 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 831 | $65,135 |
| Pregabalin | 1,602 | $57,806 |
| NucyntaTapentadol Hcl | 33 | $47,829 |
| PercocetOxycodone Hcl/Acetaminophen | 12 | $39,702 |
| Hysingla ErHydrocodone Bitartrate | 54 | $37,329 |
| Morphine Sulfate ErMorphine Sulfate | 1,193 | $36,587 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $238 | $712,615306 claims |
| Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca, Nucynta | $182 | $483,051734 claims |
| Redhill Biopharma Inc.Movantik | $36 | $118,184277 claims |
| AbbVieLinzess, Ubrelvy | $248 | $52,42180 claims |
| PfizerLyrica | $81 | $10,03311 claims |
| Almatica Pharma LLCGralise | $38 | $9,81514 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $65 | $7,90122 claims |
| Arbor Pharmaceuticals, Inc.Horizant | $32 | $7,44315 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 90 pain medicine providers in Kentucky.
Other pain medicine in Lexington
- Christopher MallardLexington$47K
- Mazhar RasulLexington$30K
- Stuart CowleyLexington$19K
- Michael HarnedLexington$17K
- Luis VascelloLexington$17K
- Shawn MilburnLexington$17K
- Brandon GishLexington$13K
- Timothy MimsLexington$11K
- Manoochehr MazloomdoostLexington$8K
- Maged FamLexington$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.